The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Andy Smith is a Certified Financial Planner (CFP®), licensed realtor and educator with over ...